Prosecution Insights
Last updated: October 02, 2026
Application No. 18/182,630

ATROPHY DETECTION FOR TISSUE OCCLUDED BY IMPLANTABLE INFLATION DEVICES

Non-Final OA §112
Filed
Mar 13, 2023
Priority
Mar 16, 2022 — provisional 63/269,433
Examiner
BERHANU, ETSUB D
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Boston Scientific Corporation
OA Round
3 (Non-Final)
65%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
528 granted / 809 resolved
-4.7% vs TC avg
Strong +25% interview lift
Without
With
+24.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
46 currently pending
Career history
851
Total Applications
across all art units

Statute-Specific Performance

§101
19.0%
-21.0% vs TC avg
§103
31.5%
-8.5% vs TC avg
§102
10.4%
-29.6% vs TC avg
§112
32.4%
-7.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 809 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 08 June 2026 has been entered. Drawings The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, computing a time interval based on a first intersection point between a first pressure line and a pressure value and a second intersection point between a second pressure line and the pressure value must be shown or the feature(s) canceled from claim 23. No new matter should be entered. Figure 4, which attempts to show the claimed subject matter, does not show P1a as being a time interval between a first intersection point between a first pressure line (415a) and a pressure value (430) and a second intersection point between a second pressure line (415b) and the pressure value (430), nor does it show P2a as being a time interval between a first intersection point between a first pressure line (425a) and a pressure value (430) and a second intersection point between a second pressure line (425b) and the pressure value (430). Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1, 4, 15, 16, 18, 21, and 23-29 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Regarding claims 1 and 18, the specification fails to provide support for adjusting a target pressure of an inflatable member in response to the detection of an atrophy condition. Regarding claim 23, the specification fails to provide support for determining a pressure value based on an initial plateau region of pressure data; the specification fails to provide any description of how the pressure value of claim 23 is determined. Examiner’s Note The following is a reason for the lack of prior art rejections: Regarding claim 1, none of the prior art discloses or suggests, either alone or in combination, an inflatable medical device comprising a controller configured to: compute a time interval of an initial plateau region of pressure data during an inflation cycle, and detect an atrophy condition in response to the time interval achieving a threshold condition, in combination with the other claimed elements. Regarding claim 18, none of the prior art discloses or suggests, either alone or in combination, a method comprising: computing a time interval of an initial plateau region of pressure data during an inflation cycle, and detecting an atrophy condition in response to the time interval achieving a threshold condition, in combination with the other claimed steps. Response to Arguments Applicant's arguments filed 08 June 2026 have been fully considered. Regarding the objection to the drawings, the amendments to claim 23 do not remove the claimed subject matter which is not depicted by the drawings. As such, the objection to the drawings has been maintained. Regarding the previous rejections of claims under 35 U.S.C. 112(a), the amendments to the claims have overcome some of the rejections. However, as noted in paragraph 5 above, the amendments have warranted a new rejection under 35 U.S.C. 112(a). Regarding the rejection of the claims under 35 U.S.C. 101, the amendments to claims 1 and 18 have overcome the rejection by reciting a change that is effected based on the detection of an atrophy condition. However, as noted in paragraph 5 above, the subject matter regarding this effected change is not supported by the originally filed specification. The Examiner would also like to note that if the currently rejected claims were amended to overcome the rejections set forth in this Office action, the withdrawn claims would need to be cancelled in order for the claims to proceed to allowance. Issues under 35 U.S.C. 112(a) and 35 U.S.C. 112(b) would be present in the currently withdrawn claims if considered in combination with claims 1 and 18. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ETSUB D BERHANU whose telephone number is (571)270-5410. The examiner can normally be reached Mon-Fri 9:00am-5:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at (571) 272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ETSUB D BERHANU/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Show 2 earlier events
Dec 09, 2025
Interview Requested
Dec 17, 2025
Applicant Interview (Telephonic)
Dec 17, 2025
Examiner Interview Summary
Dec 19, 2025
Response Filed
Mar 09, 2026
Final Rejection mailed — §112
Jun 08, 2026
Request for Continued Examination
Jun 17, 2026
Response after Non-Final Action
Aug 17, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741148
Methods and Systems for Treating Neurological Movement Disorders
8y 10m to grant Granted Sep 22, 2026
Patent 12708285
OXYGEN MASK RESPIROMETER
3y 11m to grant Granted Aug 18, 2026
Patent 12702325
SKIN FLAP THICKNESS ESTIMATION
3y 4m to grant Granted Aug 11, 2026
Patent 12697058
SYSTEMS AND METHODS FOR SEIZURE DETECTION BASED ON CHANGES IN ELECTROENCEPHALOGRAM (EEG) NON-LINEARITIES
2y 2m to grant Granted Aug 04, 2026
Patent 12690820
DETECTION OF PROLONGED POSTPRANDIAL HYPERGLYCEMIA, GLYCEMIC PEAK LINEAR PREDICTION AND INSULIN DELIVERY ADJUSTMENT
2y 9m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
65%
Grant Probability
90%
With Interview (+24.8%)
3y 6m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 809 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month